U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07310758) titled 'Contrast-enhanced Ultrasound for Sentinel Node Detection' on Dec. 16.
Brief Summary: This is a prospective single-center interventional non-inferiority study where subjects are participating for one day for patients 18 years or older with melanoma, breast cancer or head & neck cancer (including melanoma of head and neck area) and scheduled for a surgical SN procedure in the NKI-AvL without any contra-indication for Sonazoid contrast agent, such as an allergy to eggs or egg products. The primary objective is to assess the sensitivity of CEUS for intra-operative SN localization compared to the gold standard (99mTc nanocolloid). Second...